Pressmeddelande

Arctic Bioscience – Mandatory notification of trade

Cision Publicerad: 18 Oct 20:15

Eggesbø Eiendom AS, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today sold 520,240 shares in Arctic Bioscience at an average price of NOK 2,23 per share. Following the transaction, Eggesbø Eiendom AS holds 0 shares in Arctic Bioscience.

Member of the Board at Arctic Bioscience, Per Magne Eggesbø, is the chairman of the board and CEO of Eggesbø Eiendom AS, and owns 21% of the company.

Please refer to the attached notification of trading for further details.

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and the Norwegian Securities Trading Act § 5-12.

Bifogade filer

20241018 - Appendix 3 - Notifying Transactions - Eggesbø Eiendom AShttps://mb.cision.com/Public/20422/4053661/b9903eab9905996d.pdf

Nyheter om Arctic Bioscience

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!